NeuroSync Market Forecasts to 2034 – Global Analysis By Product Type (Eye-Tracking Analytics Software, VR-Based Assessment Platforms, Wearable Neuro-Monitoring Devices, Cognitive Performance Platforms, Fatigue and Concussion Monitoring and Brain Health Assessment Tools), Technology, Application, End User and By Geography
According to Stratistics MRC, the Global NeuroSync Market is accounted for $0.6 billion in 2026 and is expected to reach $1.2 billion by 2034 growing at a CAGR of 9.0% during the forecast period. NeuroSync refers to integrated neurotechnology platforms that combine eye-tracking analytics, electroencephalography monitoring, and artificial intelligence to assess, track, and optimize brain function and cognitive performance. These systems capture and analyze real-time neural and ocular data to evaluate attention, fatigue, concussion status, and cognitive load across diverse applications. NeuroSync technology encompasses wearable headsets with embedded sensors, software analytics platforms, and cloud-based data infrastructure that process multimodal biometric signals. The technology enables objective measurement of brain health indicators that were previously accessible only through specialized clinical equipment, bringing neurodiagnostic capabilities to sports venues, military operations, and consumer wellness applications.
Market Dynamics:
Driver:
Sports concussion awareness
Growing recognition of long-term neurological consequences from repeated head impacts drives demand for objective concussion assessment tools across professional and amateur sports organizations. Regulatory bodies mandate baseline cognitive testing and post-injury evaluation protocols that NeuroSync technology efficiently delivers. Athlete health and safety initiatives prioritize evidence-based return-to-play decisions over subjective symptom reporting. Insurance and liability considerations compel sports organizations to implement comprehensive brain health monitoring programs. Parental concerns about youth sports safety expand addressable markets beyond professional leagues to educational institutions.
Restraint:
Data privacy concerns
Collection and storage of detailed neurological data raises significant privacy concerns that complicate commercial deployment and user adoption. Brain data represents highly sensitive personal information with potential implications for employment, insurance, and legal proceedings. Regulatory frameworks for neural data protection remain underdeveloped, creating compliance uncertainty for developers and users. Cross-border data transfer restrictions limit cloud-based analytics capabilities for multinational deployments. Consumer skepticism regarding data security practices of technology companies extends to neurotechnology applications.
Opportunity:
Consumer wellness market expansion
The growing consumer interest in personal health optimization creates substantial opportunities for NeuroSync applications beyond clinical and sports contexts. Wearable neurotechnology enables individuals to monitor cognitive performance, stress levels, and sleep quality through accessible consumer devices. Integration with fitness and wellness ecosystems expands market reach to health-conscious populations. Gamification of brain health metrics encourages sustained user engagement and data collection. Direct-to-consumer sales models bypass traditional healthcare procurement barriers and accelerate market penetration.
Threat:
Medical device regulatory scrutiny
NeuroSync products that make diagnostic or therapeutic claims face increasingly stringent medical device regulations that extend development timelines and increase compliance costs. Regulatory agencies scrutinize the clinical validity of algorithm-based assessments compared to established diagnostic methods. Software as a medical device classification requirements impose quality management systems and documentation burdens. International regulatory harmonization remains incomplete, necessitating multiple approval processes for global market access. Adverse event reporting requirements create reputational and legal exposure for manufacturers.
Covid-19 Impact:
The COVID-19 pandemic disrupted sports seasons and clinical research programs that represented primary NeuroSync application venues, temporarily reducing market demand. However, the crisis accelerated telehealth adoption and remote patient monitoring acceptance that expanded deployment models beyond traditional settings. Healthcare providers recognized the value of remote cognitive assessment tools for patients unable to visit clinics. Post-pandemic, hybrid care models persist that combine in-person and remote neurodiagnostic services. The emphasis on resilient healthcare infrastructure supports continued investment in distributed neurotechnology capabilities.
The eye-tracking analytics software segment is expected to be the largest during the forecast period
The eye-tracking analytics software segment is expected to account for the largest market share during the forecast period, due to mature technology with established clinical validation and relatively lower deployment costs compared to full neuroimaging systems. Eye movement patterns provide reliable indicators of cognitive load, fatigue, and neurological impairment that support diverse applications. The segment benefits from integration with existing display and camera infrastructure, reducing implementation barriers. Research institutions and sports organizations extensively utilize eye-tracking for performance optimization and concussion baseline testing. Software-based delivery enables scalable deployment across large user populations.
The EEG integration segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the EEG integration segment is predicted to witness the highest growth rate, driven by increasing demand for real-time brain activity monitoring and advanced neurofeedback applications across healthcare, research, and cognitive performance domains. The ability of EEG-integrated platforms to capture precise neural signals and generate actionable insights is accelerating adoption in brain-computer interfaces, mental wellness solutions, and neurological disorder management. Furthermore, advancements in wearable EEG devices, AI-powered signal processing, and cloud-based neuroanalytics are enhancing data accuracy and usability. Growing investments in neuroscience innovation and personalized cognitive optimization technologies are expected to further strengthen the segment’s expansion within the NeuroSync Market.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to concentrated professional sports leagues with substantial resources for athlete health technologies and established concussion litigation driving investment in objective assessment tools. The United States military maintains extensive research programs for combat readiness and traumatic brain injury monitoring. Leading neurotechnology companies including NeuroSync Inc., SyncThink, and Tobii maintain headquarters and primary operations in North America. Venture capital funding for brain health technology concentrates in Boston, San Francisco, and other major technology hubs. Regulatory frameworks for software-based diagnostic tools are relatively well-established.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding sports industries in China, India, and Southeast Asia that increasingly adopt Western-standard athlete safety protocols. Government investment in neuroscience research and brain health initiatives accelerates technology development and commercialization. Aging populations in Japan and South Korea drive demand for cognitive monitoring and dementia prevention applications. Manufacturing capabilities in the region enable cost-effective production of wearable neurotechnology hardware. Growing esports industries create novel applications for attention and performance monitoring among professional gamers.
Key players in the market
Some of the key players in NeuroSync Market include NeuroSync Inc., SyncThink Inc., Tobii AB, Smart Eye AB, BrainScope Company Inc., Neural Analytics Inc., Medtronic plc, Abbott Laboratories, GE HealthCare Technologies Inc., Siemens Healthineers AG, Philips Healthcare, Microsoft Corporation, Meta Platforms Inc., Magic Leap Inc., EMOTIV Inc. and NeuroPace Inc..
Key Developments:
In May 2026, NeuroSync Inc. launched a next-generation wearable headset with integrated EEG and eye-tracking sensors capable of real-time cognitive load assessment for industrial safety applications.
In April 2026, Tobii AB expanded its eye-tracking analytics platform with AI-powered concussion detection algorithms validated through partnerships with major European football leagues.
In March 2026, SyncThink Inc. received FDA clearance for updated virtual reality-based ocular motor assessment tools designed for rapid sideline concussion evaluation in sports settings.
Product Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Market Dynamics:
Driver:
Sports concussion awareness
Growing recognition of long-term neurological consequences from repeated head impacts drives demand for objective concussion assessment tools across professional and amateur sports organizations. Regulatory bodies mandate baseline cognitive testing and post-injury evaluation protocols that NeuroSync technology efficiently delivers. Athlete health and safety initiatives prioritize evidence-based return-to-play decisions over subjective symptom reporting. Insurance and liability considerations compel sports organizations to implement comprehensive brain health monitoring programs. Parental concerns about youth sports safety expand addressable markets beyond professional leagues to educational institutions.
Restraint:
Data privacy concerns
Collection and storage of detailed neurological data raises significant privacy concerns that complicate commercial deployment and user adoption. Brain data represents highly sensitive personal information with potential implications for employment, insurance, and legal proceedings. Regulatory frameworks for neural data protection remain underdeveloped, creating compliance uncertainty for developers and users. Cross-border data transfer restrictions limit cloud-based analytics capabilities for multinational deployments. Consumer skepticism regarding data security practices of technology companies extends to neurotechnology applications.
Opportunity:
Consumer wellness market expansion
The growing consumer interest in personal health optimization creates substantial opportunities for NeuroSync applications beyond clinical and sports contexts. Wearable neurotechnology enables individuals to monitor cognitive performance, stress levels, and sleep quality through accessible consumer devices. Integration with fitness and wellness ecosystems expands market reach to health-conscious populations. Gamification of brain health metrics encourages sustained user engagement and data collection. Direct-to-consumer sales models bypass traditional healthcare procurement barriers and accelerate market penetration.
Threat:
Medical device regulatory scrutiny
NeuroSync products that make diagnostic or therapeutic claims face increasingly stringent medical device regulations that extend development timelines and increase compliance costs. Regulatory agencies scrutinize the clinical validity of algorithm-based assessments compared to established diagnostic methods. Software as a medical device classification requirements impose quality management systems and documentation burdens. International regulatory harmonization remains incomplete, necessitating multiple approval processes for global market access. Adverse event reporting requirements create reputational and legal exposure for manufacturers.
Covid-19 Impact:
The COVID-19 pandemic disrupted sports seasons and clinical research programs that represented primary NeuroSync application venues, temporarily reducing market demand. However, the crisis accelerated telehealth adoption and remote patient monitoring acceptance that expanded deployment models beyond traditional settings. Healthcare providers recognized the value of remote cognitive assessment tools for patients unable to visit clinics. Post-pandemic, hybrid care models persist that combine in-person and remote neurodiagnostic services. The emphasis on resilient healthcare infrastructure supports continued investment in distributed neurotechnology capabilities.
The eye-tracking analytics software segment is expected to be the largest during the forecast period
The eye-tracking analytics software segment is expected to account for the largest market share during the forecast period, due to mature technology with established clinical validation and relatively lower deployment costs compared to full neuroimaging systems. Eye movement patterns provide reliable indicators of cognitive load, fatigue, and neurological impairment that support diverse applications. The segment benefits from integration with existing display and camera infrastructure, reducing implementation barriers. Research institutions and sports organizations extensively utilize eye-tracking for performance optimization and concussion baseline testing. Software-based delivery enables scalable deployment across large user populations.
The EEG integration segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the EEG integration segment is predicted to witness the highest growth rate, driven by increasing demand for real-time brain activity monitoring and advanced neurofeedback applications across healthcare, research, and cognitive performance domains. The ability of EEG-integrated platforms to capture precise neural signals and generate actionable insights is accelerating adoption in brain-computer interfaces, mental wellness solutions, and neurological disorder management. Furthermore, advancements in wearable EEG devices, AI-powered signal processing, and cloud-based neuroanalytics are enhancing data accuracy and usability. Growing investments in neuroscience innovation and personalized cognitive optimization technologies are expected to further strengthen the segment’s expansion within the NeuroSync Market.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to concentrated professional sports leagues with substantial resources for athlete health technologies and established concussion litigation driving investment in objective assessment tools. The United States military maintains extensive research programs for combat readiness and traumatic brain injury monitoring. Leading neurotechnology companies including NeuroSync Inc., SyncThink, and Tobii maintain headquarters and primary operations in North America. Venture capital funding for brain health technology concentrates in Boston, San Francisco, and other major technology hubs. Regulatory frameworks for software-based diagnostic tools are relatively well-established.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding sports industries in China, India, and Southeast Asia that increasingly adopt Western-standard athlete safety protocols. Government investment in neuroscience research and brain health initiatives accelerates technology development and commercialization. Aging populations in Japan and South Korea drive demand for cognitive monitoring and dementia prevention applications. Manufacturing capabilities in the region enable cost-effective production of wearable neurotechnology hardware. Growing esports industries create novel applications for attention and performance monitoring among professional gamers.
Key players in the market
Some of the key players in NeuroSync Market include NeuroSync Inc., SyncThink Inc., Tobii AB, Smart Eye AB, BrainScope Company Inc., Neural Analytics Inc., Medtronic plc, Abbott Laboratories, GE HealthCare Technologies Inc., Siemens Healthineers AG, Philips Healthcare, Microsoft Corporation, Meta Platforms Inc., Magic Leap Inc., EMOTIV Inc. and NeuroPace Inc..
Key Developments:
In May 2026, NeuroSync Inc. launched a next-generation wearable headset with integrated EEG and eye-tracking sensors capable of real-time cognitive load assessment for industrial safety applications.
In April 2026, Tobii AB expanded its eye-tracking analytics platform with AI-powered concussion detection algorithms validated through partnerships with major European football leagues.
In March 2026, SyncThink Inc. received FDA clearance for updated virtual reality-based ocular motor assessment tools designed for rapid sideline concussion evaluation in sports settings.
Product Types Covered:
- Eye-Tracking Analytics Software
- VR-Based Assessment Platforms
- Wearable Neuro-Monitoring Devices
- Cognitive Performance Platforms
- Fatigue and Concussion Monitoring
- Brain Health Assessment Tools
- Eye-Tracking Technology
- EEG Integration
- AI and Machine Learning Analytics
- Virtual Reality
- Cloud-Based Data Platforms
- Sports Performance Optimization
- Concussion Diagnosis and Management
- Military and Defense
- Clinical Neurodiagnostics
- Cognitive Training
- Research and Academia
- Professional Sports Teams
- Collegiate Athletics
- Healthcare Providers
- Military Organizations
- Research Institutions
- Consumer Wellness
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
1 EXECUTIVE SUMMARY
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROSYNC MARKET, BY PRODUCT TYPE
5.1 Eye-Tracking Analytics Software
5.2 VR-Based Assessment Platforms
5.3 Wearable Neuro-Monitoring Devices
5.4 Cognitive Performance Platforms
5.5 Fatigue and Concussion Monitoring
5.6 Brain Health Assessment Tools
6 GLOBAL NEUROSYNC MARKET, BY TECHNOLOGY
6.1 Eye-Tracking Technology
6.2 EEG Integration
6.3 AI and Machine Learning Analytics
6.4 Virtual Reality
6.5 Cloud-Based Data Platforms
7 GLOBAL NEUROSYNC MARKET, BY APPLICATION
7.1 Sports Performance Optimization
7.2 Concussion Diagnosis and Management
7.3 Military and Defense
7.4 Clinical Neurodiagnostics
7.5 Cognitive Training
7.6 Research and Academia
8 GLOBAL NEUROSYNC MARKET, BY END USER
8.1 Professional Sports Teams
8.2 Collegiate Athletics
8.3 Healthcare Providers
8.4 Military Organizations
8.5 Research Institutions
8.6 Consumer Wellness
9 GLOBAL NEUROSYNC MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 NeuroSync Inc.
12.2 SyncThink Inc.
12.3 Tobii AB
12.4 Smart Eye AB
12.5 BrainScope Company Inc.
12.6 Neural Analytics Inc.
12.7 Medtronic plc
12.8 Abbott Laboratories
12.9 GE HealthCare Technologies Inc.
12.10 Siemens Healthineers AG
12.11 Philips Healthcare
12.12 Microsoft Corporation
12.13 Meta Platforms Inc.
12.14 Magic Leap Inc.
12.15 EMOTIV Inc.
12.16 NeuroPace Inc.
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROSYNC MARKET, BY PRODUCT TYPE
5.1 Eye-Tracking Analytics Software
5.2 VR-Based Assessment Platforms
5.3 Wearable Neuro-Monitoring Devices
5.4 Cognitive Performance Platforms
5.5 Fatigue and Concussion Monitoring
5.6 Brain Health Assessment Tools
6 GLOBAL NEUROSYNC MARKET, BY TECHNOLOGY
6.1 Eye-Tracking Technology
6.2 EEG Integration
6.3 AI and Machine Learning Analytics
6.4 Virtual Reality
6.5 Cloud-Based Data Platforms
7 GLOBAL NEUROSYNC MARKET, BY APPLICATION
7.1 Sports Performance Optimization
7.2 Concussion Diagnosis and Management
7.3 Military and Defense
7.4 Clinical Neurodiagnostics
7.5 Cognitive Training
7.6 Research and Academia
8 GLOBAL NEUROSYNC MARKET, BY END USER
8.1 Professional Sports Teams
8.2 Collegiate Athletics
8.3 Healthcare Providers
8.4 Military Organizations
8.5 Research Institutions
8.6 Consumer Wellness
9 GLOBAL NEUROSYNC MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 NeuroSync Inc.
12.2 SyncThink Inc.
12.3 Tobii AB
12.4 Smart Eye AB
12.5 BrainScope Company Inc.
12.6 Neural Analytics Inc.
12.7 Medtronic plc
12.8 Abbott Laboratories
12.9 GE HealthCare Technologies Inc.
12.10 Siemens Healthineers AG
12.11 Philips Healthcare
12.12 Microsoft Corporation
12.13 Meta Platforms Inc.
12.14 Magic Leap Inc.
12.15 EMOTIV Inc.
12.16 NeuroPace Inc.
LIST OF TABLES
Table 1 Global NeuroSync Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global NeuroSync Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global NeuroSync Market Outlook, By Eye-Tracking Analytics Software (2023-2034) ($MN)
Table 4 Global NeuroSync Market Outlook, By VR-Based Assessment Platforms (2023-2034) ($MN)
Table 5 Global NeuroSync Market Outlook, By Wearable Neuro-Monitoring Devices (2023-2034) ($MN)
Table 6 Global NeuroSync Market Outlook, By Cognitive Performance Platforms (2023-2034) ($MN)
Table 7 Global NeuroSync Market Outlook, By Fatigue and Concussion Monitoring (2023-2034) ($MN)
Table 8 Global NeuroSync Market Outlook, By Brain Health Assessment Tools (2023-2034) ($MN)
Table 9 Global NeuroSync Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global NeuroSync Market Outlook, By Eye-Tracking Technology (2023-2034) ($MN)
Table 11 Global NeuroSync Market Outlook, By EEG Integration (2023-2034) ($MN)
Table 12 Global NeuroSync Market Outlook, By AI and Machine Learning Analytics (2023-2034) ($MN)
Table 13 Global NeuroSync Market Outlook, By Virtual Reality (2023-2034) ($MN)
Table 14 Global NeuroSync Market Outlook, By Cloud-Based Data Platforms (2023-2034) ($MN)
Table 15 Global NeuroSync Market Outlook, By Application (2023-2034) ($MN)
Table 16 Global NeuroSync Market Outlook, By Sports Performance Optimization (2023-2034) ($MN)
Table 17 Global NeuroSync Market Outlook, By Concussion Diagnosis and Management (2023-2034) ($MN)
Table 18 Global NeuroSync Market Outlook, By Military and Defense (2023-2034) ($MN)
Table 19 Global NeuroSync Market Outlook, By Clinical Neurodiagnostics (2023-2034) ($MN)
Table 20 Global NeuroSync Market Outlook, By Cognitive Training (2023-2034) ($MN)
Table 21 Global NeuroSync Market Outlook, By Research and Academia (2023-2034) ($MN)
Table 22 Global NeuroSync Market Outlook, By End User (2023-2034) ($MN)
Table 23 Global NeuroSync Market Outlook, By Professional Sports Teams (2023-2034) ($MN)
Table 24 Global NeuroSync Market Outlook, By Collegiate Athletics (2023-2034) ($MN)
Table 25 Global NeuroSync Market Outlook, By Healthcare Providers (2023-2034) ($MN)
Table 26 Global NeuroSync Market Outlook, By Military Organizations (2023-2034) ($MN)
Table 27 Global NeuroSync Market Outlook, By Research Institutions (2023-2034) ($MN)
Table 28 Global NeuroSync Market Outlook, By Consumer Wellness (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
Table 1 Global NeuroSync Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global NeuroSync Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global NeuroSync Market Outlook, By Eye-Tracking Analytics Software (2023-2034) ($MN)
Table 4 Global NeuroSync Market Outlook, By VR-Based Assessment Platforms (2023-2034) ($MN)
Table 5 Global NeuroSync Market Outlook, By Wearable Neuro-Monitoring Devices (2023-2034) ($MN)
Table 6 Global NeuroSync Market Outlook, By Cognitive Performance Platforms (2023-2034) ($MN)
Table 7 Global NeuroSync Market Outlook, By Fatigue and Concussion Monitoring (2023-2034) ($MN)
Table 8 Global NeuroSync Market Outlook, By Brain Health Assessment Tools (2023-2034) ($MN)
Table 9 Global NeuroSync Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global NeuroSync Market Outlook, By Eye-Tracking Technology (2023-2034) ($MN)
Table 11 Global NeuroSync Market Outlook, By EEG Integration (2023-2034) ($MN)
Table 12 Global NeuroSync Market Outlook, By AI and Machine Learning Analytics (2023-2034) ($MN)
Table 13 Global NeuroSync Market Outlook, By Virtual Reality (2023-2034) ($MN)
Table 14 Global NeuroSync Market Outlook, By Cloud-Based Data Platforms (2023-2034) ($MN)
Table 15 Global NeuroSync Market Outlook, By Application (2023-2034) ($MN)
Table 16 Global NeuroSync Market Outlook, By Sports Performance Optimization (2023-2034) ($MN)
Table 17 Global NeuroSync Market Outlook, By Concussion Diagnosis and Management (2023-2034) ($MN)
Table 18 Global NeuroSync Market Outlook, By Military and Defense (2023-2034) ($MN)
Table 19 Global NeuroSync Market Outlook, By Clinical Neurodiagnostics (2023-2034) ($MN)
Table 20 Global NeuroSync Market Outlook, By Cognitive Training (2023-2034) ($MN)
Table 21 Global NeuroSync Market Outlook, By Research and Academia (2023-2034) ($MN)
Table 22 Global NeuroSync Market Outlook, By End User (2023-2034) ($MN)
Table 23 Global NeuroSync Market Outlook, By Professional Sports Teams (2023-2034) ($MN)
Table 24 Global NeuroSync Market Outlook, By Collegiate Athletics (2023-2034) ($MN)
Table 25 Global NeuroSync Market Outlook, By Healthcare Providers (2023-2034) ($MN)
Table 26 Global NeuroSync Market Outlook, By Military Organizations (2023-2034) ($MN)
Table 27 Global NeuroSync Market Outlook, By Research Institutions (2023-2034) ($MN)
Table 28 Global NeuroSync Market Outlook, By Consumer Wellness (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
